TCT在宫颈病变筛查中的应用价值

目的研究液基薄层细胞检测（TCT）在临床中的应用价值。方法回顾性总结2003年12月～2009年12月期间在北京市石景山中医院及北京石景山区医院行TCT、阴道镜检查及病理组织细胞学活检病例共1678例。结果TCT结果与组织病理学诊断符合率：低度鳞状上皮内病变（LSIL）为40％、高度鳞状上皮内病变（HSIL）为68．5％、恶性肿瘤（Ca）为100％。阴道镜检查与组织病理学诊断符合率：宫颈癌前病变（CINI）为56．39％、CIN2为52．48％、CIN3为89．3％、ca为100％。结论TCT检查在宫颈癌筛查中占主导地位，但有一定的假阴性及假阳性率。

The application of TCT in cervical lesions screening

Objective To study the value of TCT in the clinical application. Methods We summarized 1678 examples of the TCT, colposcopy and pathological organization cytology biopsy cases retrospectively in Beijing Shijingshan Chinese Medicine Hospital and Beijing Shijingshan Hospital during the period of May 2003 and 2009 years in may. Results The results of TCT and organization pathology diagnosis coincidence rate. LSIL is 40% , HSIL is 68.5% , Ca is 100%. Colposcopy and pathological diagnosis rate： CIN1 is 56.39% , CIN2 is 52.48%, CIN3 is 89.3% , Ca is 100%. Conclusion TCT ex- amination occupies the dominant position in cervical cancer screening, but has certain rate of missed diagnosis and the error diagnostic rate.